Clinical trials recruiting in Red Oak, Texas
7
Recruiting trials
15
Conditions
Phase breakdown
Phase 1 1Phase 2 3Phase 3 3
Conditions recruiting in Red Oak, Texas
Recruiting trials in Red Oak, Texas
- A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
- A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
- A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
- A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
- AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Common questions
How many clinical trials are recruiting in Red Oak, Texas?
7 recruiting trials have at least one study site in Red Oak, Texas.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.